SCHEMBL788260

SCHEMBL788260

c1ccc(-c2cc(-c3ccccc3)c3sc4c(-c5ccc6[nH]c7ccc(-c8cc(-c9ccccc9)cc9c8sc8c(-c%10ccccc%10)cc(-c%10ccccc%10)cc89)cc7c6c5)cc(-c5ccccc5)cc4c3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.40
CCND1 P24385 3/20 0.40
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
WEE1 P30291 3/20 0.38
JAK2 O60674 1/20 0.37
GABRA1 P14867 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRA6 Q16445 2/20 0.36
TNKS O95271 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788608 0.96 AHR (0.43) CDK4CCND1HPGDMAPK1HTT
SCHEMBL786979 0.90 LIMK1 (0.43) CDK4CCND1MEN1KMT2AWEE1
SCHEMBL788550 0.90 LIMK1 (0.43) CDK4CCND1MEN1KMT2AWEE1
SCHEMBL788263 0.89 TNKS2 (0.41) CDK4CCND1HPGDMAPK1HTT
SCHEMBL788279 0.88 AHR (0.42) CDK4CCND1HPGDMAPK1HTT
SCHEMBL786981 0.87 LIMK1 (0.41) CDK4CCND1MEN1KMT2AWEE1
SCHEMBL788612 0.86 ALOX5 (0.48) CDK4CCND1HPGDMAPK1HTT
SCHEMBL10227377 0.86 LIMK1 (0.40) CDK4CCND1HPGDMAPK1HTT
SCHEMBL10227353 0.86 LIMK1 (0.40) CDK4CCND1HPGDMAPK1HTT
SCHEMBL788701 0.85 TNKS (0.39) CDK4CCND1HPGDMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9450188-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-09-20 US disclosed
US-20140145175-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-29 US disclosed
US-8642782-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-02-04 US disclosed
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SLC39A3, SULT1A1, NUTF2 CDK4 194/4885CCND1 269/4885HPGD 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.